These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 25622905

  • 1. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.
    Wendt MK, Williams WK, Pascuzzi PE, Balanis NG, Schiemann BJ, Carlin CR, Schiemann WP.
    Neoplasia; 2015 Jan; 17(1):124-33. PubMed ID: 25622905
    [Abstract] [Full Text] [Related]

  • 2. The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.
    Izumchenko E, Chang X, Michailidi C, Kagohara L, Ravi R, Paz K, Brait M, Hoque MO, Ling S, Bedi A, Sidransky D.
    Cancer Res; 2014 Jul 15; 74(14):3995-4005. PubMed ID: 24830724
    [Abstract] [Full Text] [Related]

  • 3. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U.
    Cancer Discov; 2015 May 15; 5(5):534-49. PubMed ID: 25735773
    [Abstract] [Full Text] [Related]

  • 4. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
    Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR.
    J Biol Chem; 2013 Jun 21; 288(25):17954-67. PubMed ID: 23653350
    [Abstract] [Full Text] [Related]

  • 5. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
    Zhang H, Liu W, Wang Z, Meng L, Wang Y, Yan H, Li L.
    Tumori; 2018 Jun 21; 104(3):221-231. PubMed ID: 29714661
    [Abstract] [Full Text] [Related]

  • 6. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
    Endo H, Okami J, Okuyama H, Nishizawa Y, Imamura F, Inoue M.
    Oncogene; 2017 May 18; 36(20):2824-2834. PubMed ID: 27893711
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP.
    Breast Cancer Res; 2014 Mar 11; 16(2):R24. PubMed ID: 24618085
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
    Kang DH, Jung SS, Yeo MK, Lee DH, Yoo G, Cho SY, Oh IJ, Kim JO, Park HS, Chung C, Lee JE.
    BMC Cancer; 2020 Jun 18; 20(1):571. PubMed ID: 32552717
    [Abstract] [Full Text] [Related]

  • 10. Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.
    Zhang L, Ngo JA, Wetzel MD, Marchetti D.
    Neoplasia; 2015 Jan 18; 17(1):101-13. PubMed ID: 25622903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.
    Siu A, Virtanen C, Jongstra J.
    Oncotarget; 2011 Dec 18; 2(12):1134-44. PubMed ID: 22193779
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
    Li M, Yang J, Zhang L, Tu S, Zhou X, Tan Z, Zhou W, He Y, Li Y.
    J Exp Clin Cancer Res; 2019 May 22; 38(1):211. PubMed ID: 31118055
    [Abstract] [Full Text] [Related]

  • 18. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.
    Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.